Clearside Biomedical (Germany) Performance
| CLM Stock | EUR 0.91 0.01 1.09% |
The firm shows a Beta (market volatility) of -0.0877, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Clearside Biomedical are expected to decrease at a much lower rate. During the bear market, Clearside Biomedical is likely to outperform the market. At this point, Clearside Biomedical has a negative expected return of -0.0557%. Please make sure to confirm Clearside Biomedical's jensen alpha, skewness, and the relationship between the variance and treynor ratio , to decide if Clearside Biomedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Clearside Biomedical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 17.6 M | |
| Free Cash Flow | -10.7 M |
Clearside |
Clearside Biomedical Relative Risk vs. Return Landscape
If you would invest 95.00 in Clearside Biomedical on November 2, 2024 and sell it today you would lose (4.00) from holding Clearside Biomedical or give up 4.21% of portfolio value over 90 days. Clearside Biomedical is producing return of less than zero assuming 1.8563% volatility of returns over the 90 days investment horizon. Simply put, 16% of all stocks have less volatile historical return distribution than Clearside Biomedical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Clearside Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearside Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clearside Biomedical, and traders can use it to determine the average amount a Clearside Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.03
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLM |
Estimated Market Risk
| 1.86 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Clearside Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearside Biomedical by adding Clearside Biomedical to a well-diversified portfolio.
Clearside Biomedical Fundamentals Growth
Clearside Stock prices reflect investors' perceptions of the future prospects and financial health of Clearside Biomedical, and Clearside Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clearside Stock performance.
| Current Valuation | 17.17 M | |||
| Price To Book | 3.77 X | |||
| Price To Sales | 2.67 X | |||
| Revenue | 29.57 M | |||
| EBITDA | (449 K) | |||
| Cash Flow From Operations | (10.73 M) | |||
| Total Asset | 42.9 M | |||
About Clearside Biomedical Performance
Assessing Clearside Biomedical's fundamental ratios provides investors with valuable insights into Clearside Biomedical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Clearside Biomedical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Clearside Biomedical performance evaluation
Checking the ongoing alerts about Clearside Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clearside Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clearside Biomedical generated a negative expected return over the last 90 days | |
| Clearside Biomedical has some characteristics of a very speculative penny stock | |
| Clearside Biomedical generates negative cash flow from operations |
- Analyzing Clearside Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clearside Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Clearside Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clearside Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clearside Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clearside Biomedical's stock. These opinions can provide insight into Clearside Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Clearside Stock Analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.